Updates

February 28, 2020February 28, 2020
FDA Approves Nerlynx-Capecitabine Combo for HER2-positive Metastatic Breast Cancer

Nerlynx (neratinib) is now approved in the U.S. for use, in combination with capecitabine, to treat HER2-positive breast cancer patients who have received ... Read more
February 26, 2020February 26, 2020
New Formulation of Roche’s Perjeta-Herceptin Combo for HER2-Positive Breast Cancer Up for Possible FDA Approval

The U.S. Food and Drug Administration (FDA) will review Roche’s application seeking regulatory approval for a new formulation — given as a subcutaneous, or ... Read more
February 24, 2020February 24, 2020
Magseed Approval Extended in Europe for Soft Tissues, Long-Term Implantation

Magseed, a small magnetic marker by Endomag designed to accurately mark the site of cancer cells before surgery, is now approved in Europe for ... Read more
February 21, 2020February 21, 2020
Adding Keytruda to Chemo Slows Worsening in Advanced TNBC with PD-L1 Markers, Trial Finds

First-line treatment with Keytruda (pembrolizumab) and chemotherapy prolongs the time without disease worsening in people with advanced triple-negative breast cancer (TNBC) whose tumors are positive ... Read more
February 19, 2020February 19, 2020
Tucatinib Granted FDA Priority Review for Advanced HER2-positive Breast Cancer

The U.S. Food and Drug Administration (FDA) has granted priority review to Seattle Genetics’ application seeking approval of its investigational therapy tucatinib, in combination with trastuzumab and Xeloda (capecitabine), for treating people with locally ... Read more

News

Tutu Project’s Pilot Program Helps Breast Cancer Patients Directly With Daily Expenses
February 17, 2020February 17, 2020
The Tutu Project has awarded its first direct grants to patients and families battling ...
News

AutoNation Donates $720K to Breast Cancer Research Foundation
February 14, 2020February 26, 2020
As part of its Drive Pink initiative, AutoNation has donated $720,000 to the Breast ...
News

Study of Treatment Aiming to Prevent Advanced Breast Cancer’s Spread to Bone Doses 1st Patient
February 7, 2020
GlycoMimetics announced that the first patient with advanced breast cancer has been dosed in a ...
News

Keytruda-Mektovi Combo Deemed Safe in Early Triple Negative Breast Cancer Trial
February 6, 2020February 12, 2020
A combination of the immune checkpoint inhibitor Keytruda (pembrolizumab) and the melanoma therapy Mektovi ...
News

Researcher Awarded $462K NIH Grant to Study Effects of Endocrine Disruptors on Breast Cancer Risk in Young Women
February 3, 2020
Research efforts to understand the effects of endocrine-disrupting chemicals (EDCs) on breast cancer risk ...
News

Susan G. Komen Tissue Bank Teams with LifeOmic to Advance Breast Cancer Research
January 31, 2020January 31, 2020
A partnership between the Susan G. Komen Tissue Bank and LifeOmic, a software company, aims ...

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

Ziskin Prize Winners Will Collaborate to Further Immune Checkpoint Inhibitors for Treating Breast Cancer
January 30, 2020February 5, 2020
Two prominent breast cancer scientists will use their shared $250,000 Stand Up To Cancer ...
Artificial Intelligence Could Aid in Breast Cancer Screening, Study Shows
January 29, 2020January 29, 2020
An artificial intelligence model outperformed certified radiologists in diagnosing breast cancer from mammogram images, according to ...
Younger Women Planning Infertility Treatments Should First Receive Mammogram Screening, Study Suggests
January 27, 2020
Phase 2 Trial of Triple Combo in Treating Advanced Breast Cancer Opening, Zymeworks Says
January 24, 2020February 6, 2020
New Imaging Technique Measures Breast Cancer Metabolism
January 21, 2020February 14, 2020
Leronlimab Combo Shows Promise for Metastatic TNBC in Early Phase 1b/2 Trial Data
January 20, 2020January 20, 2020

New Method Using Sound Waves May Stop Breast Cancer Spread in Lymph Nodes, Mouse Study Shows
January 17, 2020January 21, 2020
A new method that uses sound waves to release chemotherapy in lymph nodes invaded ...
CytoDyn Files for FDA Breakthrough Therapy Status for Leronlimab for Metastatic TNBC
January 14, 2020January 22, 2020
Certain Genomic Tests May Soon Be Reimbursable for Breast Cancer Patients in Germany
January 13, 2020January 13, 2020
Keytruda, Imprime PGG Combo Increases Overall Survival in Metastatic Triple-negative BC, Data Show
January 10, 2020January 10, 2020

Arimidex ‘Highly Effective’ at Reducing Long-term Breast Cancer Rates in At-risk Women, Study Finds
January 8, 2020January 8, 2020
Postmenopausal women at increased risk of breast cancer are half as likely to develop ...
Enhertu Gets FDA Approval for Treatment of Advanced HER2-positive Breast Cancer
January 2, 2020January 3, 2020
Seattle Genetics Seeks Tucatinib’s Approval by FDA for Advanced HER2-positive Breast Cancer
December 30, 2019January 6, 2020

News

FDA Grants Breakthrough Therapy Status to Tucatinib for Advanced HER2-Positive Breast Cancer
December 19, 2019January 15, 2020
The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to Seattle ...
News

TAVO Boosts Responses to Keytruda in Triple-negative Breast Cancer Patients, Interim Phase 2 Data Show
December 18, 2019January 15, 2020
Treatment with TAVO (intratumoral IL-12) appears to increase the sensitivity of previously treated advanced ...
News

Dosing Complete in Phase 2 Trial Evaluating Lymfactin for BC Treatment-Associated Lymphedema
December 17, 2019January 15, 2020
Herantis Pharma has completed patient dosing in its Phase 2 trial evaluating the investigational ...
News

Breast Cancer Index Identifies Women Likely to Benefit From Extended Hormone Therapy, Latest Data Show
December 16, 2019
The Breast Cancer Index, a molecular test developed by Biotheranostics, successfully identified a group ...
News

FDA Approves FoundationOne CDx as Companion Diagnostic Test for Piqray Treatment
December 11, 2019December 11, 2019
The U.S. Food and Drug Administration (FDA) has approved Foundation Medicine’s FoundationOne CDx as ...
News

HHS Grant to Advance Breast Cancer Screenings Based on Ultrasound
December 9, 2019
A U.S. Department of Health and Human Services grant will fund research at two universities ...
News

CHMP Favors Kadcyla Approval in EU for Certain HER2-positive Early Breast Cancer Patients
December 6, 2019
The Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines Agency, ...
News

Weight Loss Surgery May Lower Risk of Breast Cancer, Research Suggests
December 4, 2019
Weight loss surgery may reduce the risk of developing breast cancer in obese individuals, ...
News

More Than $850M Raised for Inflammatory Breast Cancer Research
November 15, 2019November 15, 2019
Susan G. Komen, the Inflammatory Breast Cancer (IBC) Research Foundation, and the Milburn Foundation ...
News

Fertility Clinics and Breast Cancer ‘Previvor’ Team Up to Raise Awareness About Genetic Risk of Disease
November 13, 2019
For patients with gene mutations that increase their risk for diseases such as breast ...
News

Blood Test May Identify Breast Cancer Years Before Symptoms Appear, Pilot Study Suggests
November 11, 2019November 11, 2019
A simple blood test – which measures antibodies against certain tumor proteins, or antigens ...
News

Most Breast Cancers Found by Hand, MammaCare Researchers Say
November 8, 2019November 8, 2019
Decades after establishing the recognized standard for performing and teaching clinical and personal breast ...
News

First Patient Dosed in Phase 3 Trial of Tucatinib-Kadcyla Combo for Advanced HER2-Positive Breast Cancer
November 6, 2019
A Phase 3 trial exploring a combination of Seattle Genetics‘ tucatinib plus standard Kadcyla ...
News

Hormone Therapy Has More Long-term Impact on Quality of Life Than Chemo, Study Suggests
November 4, 2019
Challenging conventional wisdom, new findings suggest that hormone therapy may have a greater impact ...
News

Pathologist Creates Program Allowing Patients to Face Their Cancer Head-on
November 1, 2019December 30, 2019
Massachusetts pathologist Lija Joseph, MD, has created an innovative program that allows patients, including ...
News

Seattle Genetics’ Tucatinib Extends Survival Outcomes in Metastatic HER2-positive Breast Cancer Patients, Phase 2 Trial Shows
October 30, 2019
People with HER-positive advanced breast cancer who received multiple HER-targeted therapies have significantly better ...
News

FDA Supports Use of Anti-diarrheal Medications with Nerlynx
October 28, 2019October 28, 2019
The U.S. label of Nerlynx (neratinib), a treatment for early stage HER2-positive breast cancer, now includes ...
News

Bempegaldesleukin-Opdivo Combo Leads to Prolonged Responses in TNBC Patients, Phase 1/2 Trial Shows
October 25, 2019November 11, 2019
Bempegaldesleukin (bempeg, NKTR-214) in combination with Opdivo (nivolumab) leads to prolonged treatment responses in ...

June 22, 2018June 22, 2018

Clinical Trial of Tamoxifen-based Gel in Reducing Breast Density Recruiting in US, EU

News

The ability of a gel containing a tamoxifen-byproduct to reduce breast density — associated with an increased risk of breast cancer — is now being evaluated in a recruiting Phase 3 clinical trial. Approximately half of women in ... Read more

Subscribe to our mailing list

Pin It on Pinterest